advertisement

---

Wilson JC 18

Showing records 1 to 18 | Display all abstracts from Wilson JC

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Wilson JC
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Wilson JC
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Sarsour K
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Sarsour K
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Collinson N
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Collinson N
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Tuckwell K
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Tuckwell K
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Musselman D
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Musselman D; Klearman M
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Klearman M; Napalkov P
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Napalkov P
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Jick SS
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Jick SS
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Stone JH
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Stone JH
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Meier CR
Seminars in Arthritis & Rheumatism 2017; 46: 819-827

---

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Meier CR
Seminars in Arthritis & Rheumatism 2017; 46: 650-656

---